NCT07340853 2026-03-10
CRISPR Delivered Anti-BCMA Car-T Therapy for Relapsed or Refractory Multiple Myeloma
University of California, San Francisco
Phase 1 Recruiting
Clinical Trials
19 trialsNCT05587972 2026-02-23
Real World Treatment Experience of Patients With Breast, Lung, or GI Cancer or Multiple Myeloma Using Remote Symptom Monitoring
Carevive Systems, Inc.
Phase NA Active not recruiting
NCT04716153 2026-01-20
RE-NEZ-SENS
University Hospital, Montpellier
Phase NA Terminated
NCT07226609 2025-12-30
A Dietary Study for People With Multiple Myeloma
Memorial Sloan Kettering Cancer Center
Phase NA Recruiting
NCT04497961 2025-09-11
A Study of Health-Related Quality of Life in People With Multiple Myeloma Receiving Daratumumab or Lenalidomide
Memorial Sloan Kettering Cancer Center
Phase 2 Active not recruiting
NCT03870633 2025-01-17
Assessment of Financial Difficulty in Participants with Chronic Lymphocytic Leukemia and Multiple Myeloma
Alliance for Clinical Trials in Oncology
Completed
NCT01793051 2021-11-24
Intervention for Symptom Burden During Maintenance Therapy for Multiple Myeloma
M.D. Anderson Cancer Center
Phase 2 Completed
NCT04727294 2021-08-04
MGUS, SMM, and MM Patient Experience With Coronavirus 19 (COVID-19) Survey
HealthTree Foundation
Unknown
NCT02948283 2021-02-12
Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia
City of Hope Medical Center
Phase 1 Completed
NCT04388735 2020-05-14
Multiple Myeloma (MM) Quality of Life (QOL) Study
Massachusetts General Hospital
Unknown
NCT01413178 2020-04-21
A Randomized Trial to Compare Busulfan + Melphalan 140 mg/m2 With Melphalan 200 mg/m2 as Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma
M.D. Anderson Cancer Center
Phase 3 Completed
NCT00651937 2020-01-14
Trial of Two Stem Cell Doses To Reduce Transplant Induced Symptom Burden
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00505999 2020-01-02
Etiology of Multiple Myeloma: A Case-Control Study
M.D. Anderson Cancer Center
Unknown
NCT01875237 2019-07-16
Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene
M.D. Anderson Cancer Center
Phase 1/2 Terminated
NCT00688168 2019-05-29
Inflammatory Cytokines in Symptom Production in Multiple Myeloma
M.D. Anderson Cancer Center
Completed
NCT01927718 2019-04-29
Thalidomide to Overcome Lenalidomide Resistance After Autologous Hematopoietic Stem Cell Transplantation (HCT)
M.D. Anderson Cancer Center
Phase NA Terminated
NCT01440582 2019-03-04
Combination Therapy of Lenalidomide/Bortezomib/Dexamethasone and Panobinostat in Transplant Eligible New Diagnosed Multiple Myeloma (MM) Patients
M.D. Anderson Cancer Center
Phase 1 Completed
NCT02078518 2014-03-05
Level of Physical Activity and Its Associations With Fatigue and Quality of Life in Multiple Myeloma Survivors
National University Hospital, Singapore
Unknown
NCT00476294 2012-07-11
Long-Term Follow Up Study for AMD3100 Patients
M.D. Anderson Cancer Center
Completed